m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
FTO is an m6A demethylase. Here, the authors show that FTO promotes melanoma tumorigenicity and contributes to resistance to anti-PD1 blockade, while FTO inhibition sensitizes melanoma to anti-PD1 blockade.
Guardado en:
Autores principales: | Seungwon Yang, Jiangbo Wei, Yan-Hong Cui, Gayoung Park, Palak Shah, Yu Deng, Andrew E. Aplin, Zhike Lu, Seungmin Hwang, Chuan He, Yu-Ying He |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/88c0f0ec32fd485b963c5d3ea0d66653 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis
por: Yan-Hong Cui, et al.
Publicado: (2021) -
Correction: The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging
por: Zhong-xin Jiang, et al.
Publicado: (2021) -
Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
por: Robert A. Szczepaniak Sloane, et al.
Publicado: (2021) -
m6A demethylase FTO attenuates cardiac dysfunction by regulating glucose uptake and glycolysis in mice with pressure overload-induced heart failure
por: Beijian Zhang, et al.
Publicado: (2021) -
Phf8 histone demethylase deficiency causes cognitive impairments through the mTOR pathway
por: Xuemei Chen, et al.
Publicado: (2018)